contract_awardAwarded Tuesday, August 18, 2026Analyzed

LEIDOS BIOMEDICAL RESEARCH INC: $372M Department of Health and Human Services Contract

Bullish

Summary

Leidos Holdings ($LDOS) wins a $372M task order from NIH for NCI operations, adding ~2.4% to annual revenue. The award is a routine renewal under an existing contract, providing stable cash flow but no transformative catalyst.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.Leidos adds $372M to its backlog, representing ~2.4% of annual revenue.
  • 2.The award is a routine renewal under an existing NIH contract, not a new program.
  • 3.No direct legislative catalyst; funding comes from NIH appropriations.

Market Implications

For Leidos, this contract is a positive but expected development. The stock is already priced for steady government contracting, so the award is unlikely to drive significant price movement. It confirms the company's reliable cash flow from health IT and research support. No other publicly traded companies are directly impacted.

Full Analysis

The Department of Health and Human Services, through the National Institutes of Health, awarded Leidos Biomedical Research Inc a $372M delivery order for NCI operational support covering FY2026-FY2027. This is a task order under an existing contract, indicating continued partnership rather than new business. Leidos Holdings is the publicly traded parent, with FY2025 revenue of $15.3B. The $372M represents 2.4% of annual revenue, a meaningful but not transformative addition. No specific legislation is directly tied to this award; it is funded through NIH's base appropriations. Supply chain beneficiaries are likely small businesses in health IT and laboratory services, but no publicly traded subcontractors are identified. Historically, Leidos has consistently won large NIH contracts, and this award continues that pattern without shifting competitive dynamics.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationAug 13, 2026

Adjusting Imports of Unmanned Aircraft Systems and Unmanned Aircraft Systems Components into the United States

This proclamation imposes a 100% ad valorem tariff on imports of unmanned aircraft systems (UAS) over 25 kg, those with thermal imagers, docking stations, and certain components, and a 25% tariff on UAS under 25 kg and other components, citing national security under Section 232 of the Trade Expansion Act. It also authorizes the Department of Commerce to establish an onshoring program offering preferential tariff treatment for companies that build new U.S. manufacturing facilities for UAS and components.

presidential_memorandumAug 12, 2026

Expanding Capabilities to Combat Transnational Cyber-Enabled Crime

This memorandum establishes a government program, managed by the National Coordination Center (NCC), that authorizes private companies to conduct cyber surveillance and operations against foreign cyber-enabled transnational criminal organizations under federal oversight. It directs the Department of Justice and Department of Homeland Security to co-execute the program, requiring vetted companies to enter contracts with the government and potentially post a $1 million bond, with implementation guidance to be developed within 60 days.

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Contract Details

Recipient

LEIDOS BIOMEDICAL RESEARCH INC

Award Amount

$371,787,375

Awarding Agency

Department of Health and Human Services

Sub-Agency

National Institutes of Health

Contract Type

DELIVERY ORDER

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →